October 1, 2018

Curoverse Inc.

Acquired by Veritas Genetics in August 2017.

Provider of genomic and biomedical computing platform intended to empower scientists and clinicians to focus on making breakthrough discoveries and delivering real-world care. The company's genomic and biomedical computing platform enables patient-level genomic and health data to be securely accessible for drug development and precision medicine, enabling scientists and clinicians to manage, process, analyze and share massive biomedical data sets for everything from genomics to imaging.


BACK TO BLOG